Total Payments
$856.60
2022 Payments
$13.30
Companies
16
Transactions
68
Medicare Patients
6,107
Medicare Billing
$540,874
Payment Breakdown by Category
Food & Beverage$777.11 (90.7%)
Education$79.49 (9.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $777.11 | 63 | 90.7% |
| Education | $79.49 | 5 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $401.41 | 36 | $0 (2020) |
| Amgen Inc. | $101.43 | 8 | $0 (2022) |
| AMAG Pharmaceuticals, Inc. | $79.49 | 5 | $0 (2019) |
| CooperSurgical, Inc. | $52.38 | 3 | $0 (2020) |
| AbbVie Inc. | $37.43 | 3 | $0 (2021) |
| Astellas Pharma US Inc | $36.11 | 2 | $0 (2019) |
| Myovant Sciences Inc. | $24.74 | 2 | $0 (2021) |
| TherapeuticsMD, Inc. | $23.62 | 1 | $0 (2019) |
| KCI USA, Inc | $13.93 | 1 | $0 (2018) |
| Duchesnay USA Incorporated | $13.37 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.30 | 1 | Amgen Inc. ($13.30) |
| 2021 | $50.65 | 4 | AbbVie Inc. ($25.91) |
| 2020 | $124.81 | 9 | CooperSurgical, Inc. ($52.38) |
| 2019 | $174.00 | 11 | AMAG Pharmaceuticals, Inc. ($50.77) |
| 2018 | $221.51 | 17 | PFIZER INC. ($148.74) |
| 2017 | $272.33 | 26 | PFIZER INC. ($217.25) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/24/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Bone Health | ||||||
| 11/02/2021 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: HORMONE THERAPY | ||||||
| 10/07/2021 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: WOMENS HEALTH | ||||||
| 09/20/2021 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: HORMONE THERAPY | ||||||
| 02/09/2021 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: WOMENS HEALTH | ||||||
| 12/22/2020 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 11/12/2020 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Endocrinology | ||||||
| 09/30/2020 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: WOMENS HEALTH | ||||||
| 06/26/2020 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: NEUROLOGY | ||||||
| 06/24/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $11.59 | General |
| Category: Neurology | ||||||
| 06/02/2020 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 03/10/2020 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 02/05/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Bone Health | ||||||
| 01/22/2020 | PFIZER INC. | PREMARIN (Drug), ESTRING, COLOGUARD | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: WOMENS HEALTH | ||||||
| 12/02/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: UROLOGY | ||||||
| 10/07/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug), MAKENA | Education | In-kind items and services | $20.25 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 06/25/2019 | TherapeuticsMD, Inc. | IMVEXXY (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
| 05/14/2019 | Duchesnay USA Incorporated | Osphena (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Women's Health | ||||||
| 03/18/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $18.20 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 03/13/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Bone Health | ||||||
| 03/11/2019 | PFIZER INC. | PREMARIN (Drug), ESTRING, COLOGUARD | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: WOMENS HEALTH | ||||||
| 02/05/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Bone Health | ||||||
| 01/15/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $12.32 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 01/09/2019 | PFIZER INC. | PREMARIN (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 145 | 145 | $19,645 | $9,131 |
| 2021 | 15 | 2,801 | 5,384 | $447,922 | $254,826 |
| 2020 | 17 | 3,161 | 7,227 | $478,126 | $276,918 |
Total Patients
6,107
Total Services
12,756
Medicare Billing
$540,874
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2022 | 44 | 44 | $8,540 | $5,410 | 63.4% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 44 | 44 | $3,300 | $2,255 | 68.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 45 | $6,605 | $1,041 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $1,200 | $424.92 | 35.4% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 682 | 682 | $129,639 | $84,137 | 64.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 721 | 734 | $112,980 | $60,984 | 54.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 40 | 2,520 | $75,600 | $39,720 | 52.5% |
| 77063 | Screening digital tomography of both breasts | Office | 2021 | 682 | 682 | $51,265 | $35,524 | 69.3% |
| 76641 | Ultrasound of one breast, complete | Office | 2021 | 88 | 135 | $15,990 | $7,313 | 45.7% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 176 | 176 | $22,880 | $6,304 | 27.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 94 | $9,425 | $6,008 | 63.7% |
| 77065 | Diagnostic mammography of one breast | Office | 2021 | 58 | 65 | $9,660 | $4,343 | 45.0% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 27 | 29 | $5,800 | $2,610 | 45.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 63 | 63 | $3,150 | $2,598 | 82.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $3,275 | $1,818 | 55.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $2,200 | $1,485 | 67.5% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Office | 2021 | 57 | 62 | $3,670 | $1,327 | 36.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 41 | 47 | $1,504 | $424.71 | 28.2% |
| 81002 | Urinalysis, manual test | Office | 2021 | 61 | 68 | $884.00 | $230.20 | 26.0% |
| 77067 | Mammography of both breasts | Office | 2020 | 727 | 727 | $138,130 | $89,984 | 65.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 49 | 3,960 | $92,400 | $61,636 | 66.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 764 | 775 | $103,839 | $50,054 | 48.2% |
| 77063 | Screening digital tomography of both breasts | Office | 2020 | 727 | 727 | $54,525 | $36,900 | 67.7% |
| 76641 | Ultrasound of one breast | Office | 2020 | 107 | 163 | $14,675 | $7,912 | 53.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 121 | 148 | $13,620 | $6,932 | 50.9% |
About Dr. Rita Kirchler, M.D
Dr. Rita Kirchler, M.D is a Gynecology healthcare provider based in Florence, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659467363.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rita Kirchler, M.D has received a total of $856.60 in payments from pharmaceutical and medical device companies, with $13.30 received in 2022. These payments were reported across 68 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($777.11).
As a Medicare-enrolled provider, Kirchler has provided services to 6,107 Medicare beneficiaries, totaling 12,756 services with total Medicare billing of $540,874. Data is available for 3 years (2020–2022), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Location Florence, AL
- Active Since 10/04/2006
- Last Updated 06/17/2011
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1659467363
Products in Payments
- PREMARIN ORALS (Drug) $182.55
- PREMARIN (Drug) $113.58
- PVC (Drug) $105.28
- INTRAROSA (Drug) $79.49
- Prolia (Biological) $65.04
- Endosee (Device) $52.38
- LO LOESTRIN FE (Drug) $48.43
- EVENITY (Biological) $25.33
- MYFEMBREE (Drug) $24.74
- XTANDI (Drug) $24.18
- IMVEXXY (Drug) $23.62
- PREVENA (Device) $13.93
- Osphena (Drug) $13.37
- Tymlos (Biological) $13.04
- APLENZIN (Drug) $12.61
- FORTEO (Drug) $12.51
- SOLOSEC (Drug) $11.94
- MYRBETRIQ (Drug) $11.93
- Dayvigo (Drug) $11.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.